Rock Soffer sold $2,640 of LGVN
director at Longeveron Inc.. 2,000 shares at an average of $1.32, traded May 22, 2025, filed May 27, 2025.
Score components
- +15RoleDirector
- 0Trade size$3k at market
- 0Share of holdings soldSold 0.9% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.0%, 3m -39.0%, 6m -54.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-25-008397, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 22, 2025 | SOpen-market sale Class A Common Stock | -2,000 | $1.32 | $2,640 | 230,034 | May 27, 2025 |
Related signals
Other insiders at Longeveron Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | Longeveron Inc. | Rock Soffer director | $27k 21,000 shares | -9% | |
| 23Weak | Longeveron Inc. | Joshua Hare Chief Scientific Officer | $7,367 5,250 shares | -1% | |
| 15Weak | LGVNsell Longeveron Inc. | Khoso Baluch director | $2,588 1,250 shares | -5% | |
| 58Moderate | Longeveron Inc. | Cathy Ross director | $6,545 5,000 shares | +100% | |
| 48Moderate | Longeveron Inc. | Khoso Baluch director | $14k 10,000 shares | +200% | |
| 48Moderate | Longeveron Inc. | Jeffrey Pfeffer director | $14k 10,000 shares | +200% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.